Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor (Q33659004)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor |
scientific article |
Statements
1 reference
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor (English)
1 reference
Douglas Hough
1 reference
Dafna D Gladman
1 reference
Georg Schett
1 reference
Arthur Kavanaugh
1 reference
Philip J Mease
1 reference
Juan J Gomez-Reino
1 reference
Adewale O Adebajo
1 reference
Jürgen Wollenhaupt
1 reference
Eric Lespessailles
1 reference
Stephen Hall
1 reference
Marla Hochfeld
1 reference
ChiaChi Hu
1 reference
Randall M Stevens
1 reference
4 March 2014
1 reference
1 reference
73
1 reference
1020-1026
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference